[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE60224778D1 - Zusammensetzungen und Verfahren zur Behandlung und zur Detektion von proliferativen Störungen die mit der Überexpression des menschlichen "Transketolase like-1" gens in Zusammenhang stehen - Google Patents

Zusammensetzungen und Verfahren zur Behandlung und zur Detektion von proliferativen Störungen die mit der Überexpression des menschlichen "Transketolase like-1" gens in Zusammenhang stehen

Info

Publication number
DE60224778D1
DE60224778D1 DE60224778T DE60224778T DE60224778D1 DE 60224778 D1 DE60224778 D1 DE 60224778D1 DE 60224778 T DE60224778 T DE 60224778T DE 60224778 T DE60224778 T DE 60224778T DE 60224778 D1 DE60224778 D1 DE 60224778D1
Authority
DE
Germany
Prior art keywords
methods
treatment
gene
overexpression
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60224778T
Other languages
English (en)
Other versions
DE60224778T2 (de
Inventor
Johannes Dr Coy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE60224778D1 publication Critical patent/DE60224778D1/de
Application granted granted Critical
Publication of DE60224778T2 publication Critical patent/DE60224778T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Peptides Or Proteins (AREA)
DE2002624778 2002-04-19 2002-04-19 Zusammensetzungen und Verfahren zur Behandlung und zur Detektion von proliferativen Störungen die mit der Überexpression des menschlichen "Transketolase like-1" gens in Zusammenhang stehen Expired - Lifetime DE60224778T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20020008831 EP1354961B1 (de) 2002-04-19 2002-04-19 Zusammensetzungen und Verfahren zur Behandlung und zur Detektion von proliferativen Störungen die mit der Überexpression des menschlichen "Transketolase like-1" gens in Zusammenhang stehen

Publications (2)

Publication Number Publication Date
DE60224778D1 true DE60224778D1 (de) 2008-03-13
DE60224778T2 DE60224778T2 (de) 2009-01-22

Family

ID=28459502

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2002624778 Expired - Lifetime DE60224778T2 (de) 2002-04-19 2002-04-19 Zusammensetzungen und Verfahren zur Behandlung und zur Detektion von proliferativen Störungen die mit der Überexpression des menschlichen "Transketolase like-1" gens in Zusammenhang stehen

Country Status (10)

Country Link
US (2) US7655398B2 (de)
EP (1) EP1354961B1 (de)
JP (1) JP4239824B2 (de)
CN (3) CN1646703A (de)
AT (1) ATE384804T1 (de)
AU (1) AU2003224067A1 (de)
CA (1) CA2480276C (de)
DE (1) DE60224778T2 (de)
ES (1) ES2298304T3 (de)
WO (1) WO2003089667A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE509279T1 (de) 2005-03-07 2011-05-15 Coy Johannes Dr Verfahren zur überprüfung und kontrolle des milchsäurefermentationsprozesses/stoffwechselpf devon aerober glukosefermentation in säugerorganismen
EP1701165A1 (de) * 2005-03-07 2006-09-13 Johannes Dr. Coy Therapeutischer und diagnostischer Gebrauch von TKTL1 sowie seiner Inhibitoren und Aktivatoren
JP2016519083A (ja) * 2013-03-14 2016-06-30 アンデス バイオテクノロジーズ ソシエダード アノニマＡｎｄｅｓ Ｂｉｏｔｅｃｈｎｏｌｏｇｉｅｓ Ｓ．Ａ． 多発性骨髄腫を検出および処置するための方法
DE102021109341A1 (de) 2021-04-14 2022-10-20 TAVARGENIX GmbH TKTL1 Inhibitoren für die antivirale Therapie

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19527552C2 (de) * 1995-07-27 1999-06-24 Deutsches Krebsforsch Transketolase-verwandtes-Protein
AU7499198A (en) * 1997-05-21 1998-12-11 Johns Hopkins University, The Gene expression profiles in normal and cancer cells
US6335170B1 (en) * 1999-02-22 2002-01-01 Torben F. Orntoft Gene expression in bladder tumors
US6919185B2 (en) * 2000-05-31 2005-07-19 Bayer Aktiengesellschaft Regulation of human transketolase-like enzyme
US6727066B2 (en) * 2000-07-28 2004-04-27 Incyte Corporation Genes expressed in treated human C3A liver cell cultures
AU2002252144A1 (en) * 2001-02-27 2002-09-12 Case Western Reserve University Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer

Also Published As

Publication number Publication date
CN101684499A (zh) 2010-03-31
US20050158726A1 (en) 2005-07-21
ATE384804T1 (de) 2008-02-15
US20100136577A1 (en) 2010-06-03
WO2003089667A1 (en) 2003-10-30
CN1646703A (zh) 2005-07-27
ES2298304T3 (es) 2008-05-16
CA2480276C (en) 2011-09-13
US8216792B2 (en) 2012-07-10
EP1354961B1 (de) 2008-01-23
EP1354961A1 (de) 2003-10-22
AU2003224067A1 (en) 2003-11-03
DE60224778T2 (de) 2009-01-22
CA2480276A1 (en) 2003-10-30
CN101955997A (zh) 2011-01-26
JP4239824B2 (ja) 2009-03-18
US7655398B2 (en) 2010-02-02
JP2005523025A (ja) 2005-08-04

Similar Documents

Publication Publication Date Title
ATE519862T1 (de) Zusammensetzungen, kits und verfahren zur identifizierung, beurteilung, vorbeugung und therapie von gebärmutterhalskrebs
IS7770A (is) Hlutleysandi mótefni gegn GDF-8 og notkun theirra
DE60330181D1 (de) Actriib-fusionspolypeptide und verwendungen dafür
EP2006298A3 (de) Jugendliches Hämochromatose-Gen (HFE2A), Expressionsprodukte und Verwendungen davon
DE60130797D1 (de) Verwendung von spezifischen erbb4 antagonisten zur behandlung von stenose
ATE313532T1 (de) Diaryl- und arylheteroarylharnstoffderivate als modulatoren des 5-ht2a-serotoninrezeptors, die sich zur prophylaxe und behandlung von damit im zusammenhang stehenden erkrankungen eignen
DE60028970D1 (de) An her2 bindende peptidverbindungen
BR0315688A (pt) Compostos, composições farmacêuticas e seus usos no tratamento ou prevenção de doenças ou condições de proliferação celular metabólicas
IL197686A0 (en) Pharmaceutical compositions containing alpha-4 integrin antagonists and uses thereof in the treatment of multiple myeloma and diseases associated therewith
DE69729125D1 (de) Troponin untereinheiten und fragmente zur verwendung als inhibitoren der angiogenese
ATE540129T1 (de) Target zur therapie kognitiver behinderungen
MY140132A (en) Thiazolidin-4-one derivatives for use in the treatment of anemias
DE69732535D1 (de) Oligonucleotidzusammenstellung und verfahren zur regulierung der protein b7 expression
WO2003103581A3 (en) COMPOSITIONS AND METHODS FOR LIVER GROWTH AND PROTECTION
DE60313004D1 (de) Alpha-7-nikotinsäure-rezeptoragonisten und statine in kombination
ATE488529T1 (de) Zusammensetzungen und verfahren zur behandlung von tumoren
ATE356995T1 (de) Verfahren zur identifizierung von mitteln zur behandlung von diabetes
BR9906926A (pt) Composições e métodos para tratamento de células tendo dna de minuto duplo
MXPA05011085A (es) Composiciones y metodos relacionados a stop-1.
DE69705936D1 (de) Teil der intronsequenz des von hippel-lindau(vhl)-gens und seine verwendung zur krankheitsdiagnose
ATE473728T1 (de) Verwendung von fluoreszierenden perlylenverbindungen zur behandlung menschlicher haare
ATE313561T1 (de) Vgf polypeptide und verfahren zur behandlung von vgf-erkrankungen
DE60224778D1 (de) Zusammensetzungen und Verfahren zur Behandlung und zur Detektion von proliferativen Störungen die mit der Überexpression des menschlichen "Transketolase like-1" gens in Zusammenhang stehen
ATE174634T1 (de) Verfahren und proben zum nachweis von mit dem locus der infantilen spinalamyotrophien verbundenen markern
ATE298244T1 (de) Monoklonaler antikörper mit selektiver bindung an vgf und verwendung zur behandlung von vgf- erkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition